Ampicillin-Sulbactam
- Generic Name
- Ampicillin-Sulbactam
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
适用于产β内酰胺酶的流感嗜血杆菌、卡他莫拉菌、淋病奈瑟菌、葡萄球菌属、某些大肠埃希菌、克雷伯菌属和奇异变形杆菌、脆弱拟杆菌、不动杆菌属、肠球菌属等所致的肝胆系统、泌尿系统、皮肤软组织感染，对需氧菌与厌氧菌混合感染，特别是腹腔感染和盆腔感染尤为适用。本品对于氨苄西林敏感菌所致的上述感染液同样有效。本品不宜用于铜绿假单胞菌、枸橼酸杆菌、普罗维登斯菌、肠杆菌属、摩根菌属和沙雷菌属所致的感染。
- Associated Conditions
- -
- Associated Therapies
- -
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Petrovsky National Research Centre of Surgery
- Target Recruit Count
- 50
- Registration Number
- NCT06336213
- Locations
- 🇷🇺
Petrovsky Research National Centre of Surgery (Petrovsky NRCS), Moscow, Russian Federation
Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Beni-Suef University
- Target Recruit Count
- 213
- Registration Number
- NCT06048692
- Locations
- 🇪🇬
Beni-suef university Hospital, Banī Suwayf, Beni Suef, Egypt
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 734
- Registration Number
- NCT05922124
Antibiotic Prophylaxis in Laparoscopic Cholecystectomy
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-06-28
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- University of Roma La Sapienza
- Target Recruit Count
- 138
- Registration Number
- NCT01888822
- Locations
- 🇮🇹
Sapienza University of Rome- Polo Pontino, Terracina, Latina, Italy
Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-06-07
- Last Posted Date
- 2010-06-07
- Lead Sponsor
- Attikon Hospital
- Target Recruit Count
- 176
- Registration Number
- NCT01138852
T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2011-08-18
- Lead Sponsor
- University of Bologna
- Target Recruit Count
- 142
- Registration Number
- NCT00630513
- Locations
- 🇮🇹
S.Orsola-Malpighi University Hospital - University of Bologna, Bologna, Italy
Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-08-24
- Last Posted Date
- 2012-08-09
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Target Recruit Count
- 550
- Registration Number
- NCT00368537
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath